← Back
$RIGL All transactions

RIGEL PHARMACEUTICALS INC

A

$ Value

$0

Shares

2,500

Price

$0

Filed

May 28

Insider

Name

HANNAH ALISON L.

Title

CIK

0001645600

Roles

Director

Transaction Details

Transaction Date

2025-05-23

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

10,625

Footnotes

The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors. | This number has been adjusted to reflect the one-for-ten reverse stock split effective June 27, 2024. | The shares vest monthly over one (1) year from the date of grant, subject to the Reporting Person's continuous service on the Company's Board of Directors.

Filing Info

Accession No.

0000905148-25-001932

Form Type

4

Issuer CIK

0001034842

HANNAH ALISON L.'s History

Date Ticker Type Value
2025-06-01 NEO A $0
2025-06-01 NEO A $0
2025-06-01 NEO A $0
2025-06-01 NEO M $0
2025-05-23 RIGL A $0
2025-05-23 RIGL A $0

Other Insiders at RIGL (90d)

Insider Bought Sold Last
MOOS WALTER H $145K 2026-02-20
RODRIGUEZ RAUL R
CEO, President
2026-02-17
MILLER MICHAEL PATRICK 2026-02-01
Schorno Dean L
EVP & Chief Financial Officer
2026-02-17
Furey Raymond J.
EVP, GC, CCO & Corp Sec
2026-02-17
Santos David A
EVP, Chief Commercial Officer
2026-02-17
Rojkjaer Lisa
EVP, Chief Medical Officer
2026-02-17